Key result
Depleting YTHDF1 or p66shc alleviates cardiac fibrosis by suppressing micronuclear rupture and oxidative stress.
Why the study?
Dynamic interactions between micronuclear and mitochondrial reactive oxygen species influence micronuclear homeostasis and heart diseases, but the molecular mechanisms underlying micronuclear rupture during cardiac fibrosis remained largely unknown.
Does targeting YTHDF1-mediated m6A methylation of p66shc reduce micronuclear rupture, mitochondrial reactive oxygen species production, and cardiac fibrosis in mouse models of cardiac fibrosis?
Does targeting YTHDF1-mediated m6A methylation of p66shc reduce micronuclear rupture, mitochondrial reactive oxygen species production, and cardiac fibrosis in mouse models of cardiac fibrosis?
This preclinical study identifies an epigenetic mechanism wherein YTHDF1-mediated m6A methylation of p66shc promotes micronuclear rupture, mitochondrial ROS production, and fibroblast pyroptosis, suggesting a potential therapeutic target for cardiac fibrosis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for YTHDF1/p66shc inhibition in cardiac fibrosis; human validation required before clinical consideration.
AIMS: Dynamic interactions between micronuclear and mitochondrial reactive oxygen species influence micronuclear homeostasis and associated heart diseases. However, the molecular mechanisms underlying micronuclear rupture during cardiac fibrosis remain largely unknown. METHODS AND RESULTS: Cardiac fibroblast-specific YTHDF1-deficient and wild-type mice were treated with isoproterenol/transverse aortic constriction to induce cardiac fibrosis. To investigate the roles of YTHDF1, p66shc, and m6A modification in cardiac fibrosis, AAV9 vectors carrying a cardiac fibroblast-specific periostin promoter were used to induce p66shc overexpression or deliver small hairpin RNA targeting YTHDF1, along with the m6A inhibitor 3-deoxyadenosine. Histological and molecular biology analyses were conducted to examine how YTHDF1 regulates p66shc mRNA stability during cardiac fibrosis. Additionally, p66shc reconstitution in YTHDF1-deficient cardiac fibroblasts and mouse hearts was performed to assess its effects on micronuclear rupture and fibrosis. Human atrial fibrillation heart tissue was used to validate these findings.During cardiac fibrosis, the increased micronuclear rupture was accompanied by p66shc upregulation and excessive mitochondrial reactive oxygen species production. Fibroblast-specific p66shc depletion inhibited micronuclear rupture, mitochondrial reactive oxygen species, and fibroblast pyroptosis, and alleviated cardiac fibrosis. Notably, p66shc upregulation was correlated with elevated m6A modification of mRNA. Mechanistically, YTHDF1 recognized the m6A-modified site on p66shc mRNA, enhancing its stability and translation. Conversely, YTHDF1 knockdown inhibits the stability and expression of p66shc, leading to opposing effects. In human atrial fibrillation heart tissues, increased YTHDF1 and p66shc levels were associated with enhanced micronuclear rupture, excessive mitochondrial reactive oxygen species production, fibroblast pyroptosis, and cardiac fibrosis. CONCLUSIONS: This study revealed a novel epigenetic mechanism in which m6A methylation of p66shc drives micronuclear rupture and exacerbates cardiac fibrosis. These findings provide new insights into potential measures for preventing cardiac fibrosis. TRANSLATIONAL PERSPECTIVES: These findings reveal a clinically significant role of the YTHDF1/p66shc axis in mitigating cardiac fibrosis. Targeting m6A methylation of p66shc to suppress mitochondrial ROS generation, micronucleus rupture, and cardiac fibroblast pyroptosis may offer a promising therapeutic strategy for cardiac fibrosis.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied Cardiac fibrosis and atrial fibrillation. Fibroblast-specific p66shc depletion, YTHDF1 knockdown, or 3-deoxyadenosine vs. Wild-type controls or p66shc overexpression was evaluated on Micronuclear rupture, mitochondrial reactive oxygen species production, fibroblast pyroptosis, and cardiac fibrosis. YTHDF1-mediated m6A methylation of p66shc enhanced its mRNA stability to promote micronuclear rupture, mitochondrial ROS, and cardiac fibrosis, which were alleviated by p66shc or YTHDF1 depletion.
Synapse has enriched 10 related papers. Consider them for comparative context: